4.5 Article

Clinical relationship between blood concentration and clinical symptoms in aconitine intoxication

Journal

AMERICAN JOURNAL OF EMERGENCY MEDICINE
Volume 40, Issue -, Pages 184-187

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ajem.2020.11.005

Keywords

Aconitine intoxicity; Emergency care; Blood level

Funding

  1. Korean National Research Foundation (NRF) [NRF-2020R1I1A3074228]
  2. Chungnam National University Hospital Research Fund

Ask authors/readers for more resources

Aconitine, a toxic substance with potential therapeutic effects, can be fatal due to its high toxicity and low safety margin. Research has shown that there is no direct correlation between blood concentration of aconitine and clinical manifestations, with patients having slower symptom development but more severe clinical manifestations when blood concentration is below a certain level.
Background: Aconitine is well-known for its potential analgesic, anti-inflammatory, and circulation promoting effects and has been widely used as a folk medicine in South Korea. Owing to its extremely toxic nature and relatively low safety margin, intoxication is sometimes fatal. The toxic compound mainly affects the central nervous system, heart, and muscle, resulting in cardiovascular complications. Purpose: To determine the exact relationship between blood concentration of aconitine and clinical manifestation. Basic procedures: The National Forensic Service (NFS) was commissioned to assist in a quantitative analysis of highly toxic aconitine and corresponding blood concentrations by analyzing the body fluids of three patients who were suspected of aconitine poisoning. Main findings: Aconitine blood values tested by the NFS showed that patients with a blood concentration below a certain level developed symptoms slowly and showed a high severity of clinical manifestation. There was no correlation between blood concentration and symptoms or ECG results. Conclusions: In case of suspected aconitine poisoning, an emergency care department should be visited, even with symptomatic improvement, and the patient should be monitored for at least 24 h, depending on the level of recovery and changes in ECG results. (c) 2020 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available